Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, medical-device maker Becton, Dickinson and Co.
With that in mind, let's take a closer look at BD's business and see what CAPS investors are saying about the stock right now.
|Headquarters (founded)||Franklin Lakes, N.J. (1897)|
|Market Cap||$16.3 billion|
|Trailing-12-Month Revenue||$7.9 billion|
|Management||CEO Vincent Forlenza (since October 2011)
CFO David Elkins (since December 2008)
|Return on Capital (average, past 3 years)||14.4%|
|Cash/Debt||$2.7 billion / $4.2 billion|
Sources: S&P Capital IQ and Motley Fool CAPS.
On CAPS, 98% of the 1,146 members who have rated BD believe the stock will outperform the S&P 500 going forward.
Stable business. Good [return on equity]. Good profit margins. Fairly valued. Good long term growth rate. Plus if the market corrects this will outpermform short term I would guess. And outperform long term also.
If you want to retire rich, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future. Of course, despite its five-star rating, Becton, Dickinson and Co. may not be your top choice.
We've found another stock we are incredibly excited about -- excited enough to dub it "The Motley Fool's Top Stock for 2012." We have compiled a special free report for investors to uncover this stock today. The report is 100% free, but it won't be here forever, so click here to access it now.
Want to see how well (or not so well) the stocks in this series are performing? Follow the new TrackPoisedTo CAPS account.
Fool contributor Brian Pacampara owns no position in any of the companies mentioned. Motley Fool newsletter services have recommended buying shares of Becton, Dickinson and Covidien. The Fool owns shares of Abbott. Try any of our Foolish newsletter services free for 30 days.